Immunohistochemical Expression of Mortalin in Vitiligo Patients

PRAME (PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA) EXPRESSION IN CUTANEOUS MELANOCYTIC LESIONS

EVALUATION OF SERUM LEVEL OF CXCL12 AND ITS RELATION TO DISEASE ACTIVITY IN VITILIGO PATIENTS

Study Of Detection Of Serum CXCL10 In Vitiligo Patients

Evaluation of the Role of Apoptosis in Vitiligo: Immunohistochemical Expression of P53, Bcl-2 and MART-1 Antigens

Cutaneous Forkhead Box P3 (FOXP3) Immune-Expression in Vitiligo Patients

Histopathological Changes in Lesional and Perilesional Vitiligo Skin

The role of chemokines CXCL10 and CXCL12 in the pathogenesis of vitiligo

Assessment of C-X-C Motif Chemokine Ligand 10 (CXCL10) Serum Level in Patients with Vitiligo

Expression of Tyrosinase, Tyrp1 and Tyrp2 in vitiligo